Home
TECX
TECX News

Latest Tectonic Therapeutic Inc. Common Stock (TECX) News on May 10, 2025

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire

a day ago

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights

Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference

GlobeNewswire

3 days ago

Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference

Insider Stock Buying Reaches US$62.6m On Tectonic Therapeutic

Simply Wall St.

5 days ago

Insider Stock Buying Reaches US$62.6m On Tectonic Therapeutic

TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks Earning Wall Street’s Seal of Approval

TipRanks

9 days ago

TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks Earning Wall Street’s Seal of Approval

Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025

GlobeNewswire

25 days ago

Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 04/14/2025

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 04/10/2025

Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

GlobeNewswire

2 months ago

Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Tectonic Therapeutic to Participate in March Investor Conferences

GlobeNewswire

3 months ago

Tectonic Therapeutic to Participate in March Investor Conferences

Tectonic Announces $185 Million Private Placement

GlobeNewswire

3 months ago

Tectonic Announces $185 Million Private Placement

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF

GlobeNewswire

3 months ago

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF

Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024

GlobeNewswire

5 months ago

Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024

Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference

GlobeNewswire

5 months ago

Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference

Tectonic Therapeutic Inc. Reports Q3 2024 Results

TipRanks

6 months ago

Tectonic Therapeutic Inc. Reports Q3 2024 Results

Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein

GlobeNewswire

6 months ago

Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein

Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

6 months ago

Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights

Tectonic Therapeutic Independent Director Acquires 7.0% More Stock

Simply Wall St.

6 months ago

Tectonic Therapeutic Independent Director Acquires 7.0% More Stock

Tectonic Therapeutic to Present Phase 1a Data at AHA 2024

GlobeNewswire

7 months ago

Tectonic Therapeutic to Present Phase 1a Data at AHA 2024

Argus Research

7 months ago

Daily – Vickers Top Buyers & Sellers for 09/27/2024

Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

8 months ago

Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45

GlobeNewswire

8 months ago

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45

Tectonic Therapeutic to Participate in September Investor Conferences

GlobeNewswire

9 months ago

Tectonic Therapeutic to Participate in September Investor Conferences

Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

9 months ago

Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights

Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45

GlobeNewswire

9 months ago

Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45

Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million

Business Wire

a year ago

Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million

Share on Social Networks: